Skip Navigation

Phase II Trial of Tremelimumab in Patients with Metastatic Urothelial Cancer Previously Treated with PD-1/PD-L1 Blockade

Brief Summary

Type:
Urologic / Genitourinary - Other

Study Type:
Treatment

Phase:
II

ClinicalTrials.gov Identifier:
NCT03557918

Study #:
STUDY00144407

Start Date:
Nov 24, 2019

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT03557918

View Complete Trial Details & Eligibility at ClinicalTrials.gov